PMDA — authorised 23 June 2021
- Marketing authorisation holder: SUMITOMO DAINIPPON PHARMA Co., Ltd.
- Status: approved
PMDA authorised Twymeeg on 23 June 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 23 June 2021; PMDA has authorised it.
SUMITOMO DAINIPPON PHARMA Co., Ltd. holds the Japanese marketing authorisation.